Stockscreener 앱 받기
0.2467
5.48%
-0.0143
시간 외 거래:
.25
0.0033
+1.34%
전일 마감가:
$0.261
열려 있는:
$0.2687
하루 거래량:
1.57M
Relative Volume:
1.56
시가총액:
$13.43M
수익:
$65.27M
순이익/손실:
$-19.15M
주가수익비율:
-0.3974
EPS:
-0.6208
순현금흐름:
$-12.43M
1주 성능:
-6.94%
1개월 성능:
-35.01%
6개월 성능:
-49.75%
1년 성능:
-46.14%
1일 변동 폭
$0.2452
$0.2687
1주일 범위
$0.2452
$0.279
52주 변동 폭
$0.2452
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
명칭
Cosmos Health Inc
전화
312-536-3102
주소
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.2467 | 14.21M | 65.27M | -19.15M | -12.43M | -0.6208 |
MCK
Mckesson Corp
|
739.53 | 88.56B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
263.64 | 51.53B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
195.85 | 45.64B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
75.74 | 8.66B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.45 | 1.24B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029 - lincolnjournal.com
Cosmos Health (NASDAQ: COSM) outlines 2026 proxy, 10M-share equity plan and Series B preferred - Stock Titan
Cosmos Health reports balance sheet improvements, EIB talks By Investing.com - Investing.com South Africa
Cosmos Health reports balance sheet improvements, EIB talks - Investing.com
Cosmos Health trims $4.5M debt, weighs €25M EIB deal, drops 38% warrants - Stock Titan
Cosmos Health Provides Balance Sheet Update: Highlights - GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Cosmos Health enters animal health market with C-Scrub brand - Yahoo Finance
Cosmos Health extends C-Scrub brand into veterinary market - Investing.com
Cosmos Health enters $69B animal health market with C-Scrub Wash 4% after passing EU veterinary tests - Pluang
Cosmos Health Inc. Expands C-Scrub Brand into Veterinary Market with C-Scrub Wash 4% Launch - Quiver Quantitative
Cosmos Health (COSM) Slides 4.7% as Shares Test Key Support at $0.24RSI Overbought Alerts - thelegaladvocate.com
Cosmos Health Company Profile & Introduction - Moomoo
COSM: Cosmos Health Projects Strong Revenue Growth through 2029 - GuruFocus
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenu - The National Law Review
Cosmos Health (COSM) Forecasts FY26 Revenue Exceeding $90 Millio - GuruFocus
Cosmos Health Forecasts $200 Million Revenue by 2029 - geneonline.com
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation - Koreabizwire
Cosmos Health projects revenue to reach $200.6M by 2029 - Investing.com
Cosmos Health Releases 2026-2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation - The Manila Times
Cosmos Health targets $200 mln revenue, $44 mln adjusted EBITDA by 2029 - marketscreener.com
Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029 - TradingView
From $19M loss to $31M profit: Cosmos Health maps 2029 turnaround - Stock Titan
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash G - StreetInsider
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M - GlobeNewswire
COSM Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin; Stock EasesEarnings Outlook Update - thelegaladvocate.com
Cosmos Health Inc. (COSM) Q4 2025 Earnings: EPS Misses Estimates by Wide MarginEarnings Season Outlook - thelegaladvocate.com
Cosmos Health (COSM) Q1 2026: Revenue $17.93M Misses $21.67M Est - GuruFocus
Cosmos Health (NASDAQ: COSM) seeks shareholder votes on equity plan, Series B preferred - Stock Titan
Cosmos Health Q1 2026 Results: Record $17.9M Revenue, Liabilities Down, U.S. Expansion Underway - Minichart
Cosmos Health reports Q1 revenue up 31% to $17.9M; liabilities down $4.5M - TradingView
Cosmos Health (COSM) Q1 revenue up 31% as net loss widens - Stock Titan
Cosmos Health Reports Strong Q1 Results with Record Revenue - GuruFocus
Cosmos Health (COSM) Reports Strong Q1 2026 Revenue Growth - GuruFocus
Cosmos Health’s Series B warrants expire unexercised By Investing.com - Investing.com Nigeria
Cosmos Health’s Series B warrants expire unexercised - Investing.com
Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants - ACCESS Newswire
4.87M Cosmos Health warrants expire with no new shares issued - Stock Titan
Cosmos Health reports Q1 revenue of $17.9M, up 31% year-over-year By Investing.com - Investing.com South Africa
Cosmos Health reports Q1 revenue of $17.9M, up 31% year-over-year - Investing.com Australia
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway - ACCESS Newswire
BRIEF-Cosmos Health Q1 Revenue USD 17.9 Million - TradingView
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues Into Q2 With U.S. Expansion Underway - 富途牛牛
COSM Shows Rapid Revenue Rise - Yahoo Finance
Cosmos Health Inc. 1Q 2026: Revenue $17.93M, EPS ($0.06) — 10-Q Summary - TradingView
Cosmos Health (NASDAQ: COSM) posts Q1 loss and issues going‑concern warning - Stock Titan
Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt P - ACCESS Newswire
COSM Q1'26 Earnings: EPS estimate is (0.01) USD - TradingView
Cosmos Health Inc stock (US22143K1016): volatility after reverse split and uplisting plans draw inve - AD HOC NEWS
Cosmos Health Inc.Common Stock (NQ: COSM - FinancialContent
[NT 10-Q] Cosmos Health Inc. SEC Filing - Stock Titan
Cosmos Health Inc (COSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
0.00%
자본화:
|
볼륨(24시간):